Three miRNA Signatures in Glioma: From Molecular Mechanisms to Potential Clinical Application

Abroad (travel likely)Recruiting

Conditions

Glioma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

"Regina Elena" National Cancer Institute, Rome, Rome, Italy

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Glioblastoma (GBM) · Newly Diagnosed Glioblastoma · GBM

Abroad (travel likely)RecruitingPHASE2

Springdale, United States · Los Angeles, United States

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

IDH1 wt Allele · Recurrent Anaplastic Astrocytoma · Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Houston, United States

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

Radiation Necrosis · High Grade Glioma (III or IV) · Brain Metastasases

Abroad (travel likely)RecruitingPHASE3

Amsterdam, Netherlands · Amsterdam, Netherlands

Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease

Glioma

Abroad (travel likely)RecruitingEARLY_PHASE1

Rochester, United States